Ra Medical Systems announced that its wholly owned subsidiary, Catheter Precision, Inc., has registered its leading product, VIVO, in Switzerland and has completed first cases in the new territory. VIVO has already received FDA Clearance and successful registration with a German Competent Authority and MHRA registration allowing VIVO to be sold in the US, twenty-three countries within the European Union and the UK. For manufacturers based outside of Switzerland it is necessary to have a CH REP, or Swiss Authorized Representative, prior to marketing their medical devices in Switzerland.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on RMED:
- Ra Medical Systems’ Catheter Precision issued patent in Japan
- Ra Medical Systems announces granting of new U.S. patent
- Ra Medical Systems’ Catheter Precision announces publication of VIVO data
- Ra Medical’s Catheter Precision announces procedures using LockeT device
- Ra Medical Systems announces launch of LockeT device